Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sentinel Surveillance | 4 | 2020 | 1093 | 0.37 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2018 | 572 | 0.25 | Why? |
| France | 14 | 2021 | 12074 | 0.21 | Why? |
| Macaca fascicularis | 2 | 2021 | 1009 | 0.19 | Why? |
| Influenza, Human | 6 | 2020 | 10779 | 0.19 | Why? |
| Kingella kingae | 1 | 2018 | 15 | 0.18 | Why? |
| Neisseriaceae Infections | 1 | 2018 | 21 | 0.18 | Why? |
| Human bocavirus | 1 | 2018 | 142 | 0.17 | Why? |
| Arthritis, Infectious | 1 | 2018 | 111 | 0.16 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2021 | 846 | 0.14 | Why? |
| Seasons | 4 | 2021 | 4071 | 0.13 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.12 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.12 | Why? |
| Picornaviridae Infections | 1 | 2018 | 544 | 0.12 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.11 | Why? |
| Rhinovirus | 1 | 2018 | 979 | 0.11 | Why? |
| Influenza Vaccines | 2 | 2017 | 2941 | 0.11 | Why? |
| Serologic Tests | 2 | 2021 | 4359 | 0.10 | Why? |
| Travel | 5 | 2020 | 7220 | 0.08 | Why? |
| Epidemiological Monitoring | 2 | 2017 | 3493 | 0.08 | Why? |
| Paris | 2 | 2021 | 1287 | 0.08 | Why? |
| Respiratory Tract Infections | 3 | 2018 | 6817 | 0.08 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.08 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.07 | Why? |
| Coronavirus | 4 | 2020 | 18339 | 0.06 | Why? |
| Myocarditis | 1 | 2018 | 2731 | 0.06 | Why? |
| Contact Tracing | 2 | 2020 | 8448 | 0.06 | Why? |
| Infant | 6 | 2021 | 30274 | 0.06 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.06 | Why? |
| Fatal Outcome | 3 | 2018 | 3438 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Child, Preschool | 6 | 2021 | 36283 | 0.05 | Why? |
| Immunoprecipitation | 1 | 2020 | 300 | 0.05 | Why? |
| Gabon | 1 | 2018 | 81 | 0.05 | Why? |
| Blood | 1 | 2020 | 274 | 0.05 | Why? |
| Luciferases | 1 | 2020 | 378 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.04 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.04 | Why? |
| Urine | 1 | 2020 | 469 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.04 | Why? |
| Parvoviridae Infections | 1 | 2018 | 222 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Vaccine Potency | 1 | 2017 | 339 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.04 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Humans | 20 | 2021 | 930598 | 0.03 | Why? |
| Pericardial Effusion | 1 | 2018 | 312 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.03 | Why? |
| Male | 12 | 2021 | 367725 | 0.03 | Why? |
| Child | 5 | 2021 | 70012 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.03 | Why? |
| Pharyngitis | 1 | 2017 | 687 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2020 | 1138 | 0.03 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.03 | Why? |
| Middle Aged | 9 | 2020 | 270681 | 0.03 | Why? |
| Common Cold | 1 | 2017 | 645 | 0.03 | Why? |
| Cross Infection | 1 | 2013 | 8675 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| United Arab Emirates | 1 | 2013 | 704 | 0.03 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.02 | Why? |
| Adult | 7 | 2020 | 244371 | 0.02 | Why? |
| Primary Health Care | 2 | 2017 | 4839 | 0.02 | Why? |
| China | 3 | 2020 | 50654 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Heart Arrest | 1 | 2018 | 1239 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Headache | 1 | 2017 | 2257 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Fatigue | 1 | 2017 | 2479 | 0.02 | Why? |
| Infectious Disease Incubation Period | 1 | 2013 | 1033 | 0.02 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.02 | Why? |
| Radiography | 1 | 2013 | 1576 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Aged | 5 | 2020 | 215776 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Dyspnea | 1 | 2017 | 3847 | 0.02 | Why? |
| Cough | 1 | 2017 | 4891 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Animals | 2 | 2021 | 78931 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Fever | 1 | 2017 | 7795 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.01 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2013 | 9044 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |
| Lung | 1 | 2013 | 31049 | 0.00 | Why? |
Behillil's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(260)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_